Inj midazolam in 0.9% nacl
Products billed under this code include Midazolam HCl.
Payment limit per 1 MG, by effective quarter, 1Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Midazolam HCl.
Payment limit per 1 MG, by effective quarter, 1Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Midazolam HCl | Hikma Pharmaceuticals USA Inc. | 00143-9379-10 | 500 | $39.00 |
| Midazolam HCl | Hikma Pharmaceuticals USA Inc. | 00143-9380-10 | 1000 | $78.00 |
| Midazolam HCl | Sagent Pharmaceuticals | 25021-0688-82 | 500 | $39.00 |
| Midazolam HCl | Sagent Pharmaceuticals | 25021-0688-87 | 2000 | $156.00 |
| Midazolam HCl | WG Critical Care, LLC | 44567-0610-10 | 500 | $39.00 |
| Midazolam HCl | WG Critical Care, LLC | 44567-0611-10 | 1000 | $78.00 |
| Midazolam HCl | FreseniUS Kabi USA, LLC | 65219-0650-10 | 1000 | $78.00 |
| Midazolam HCl | FreseniUS Kabi USA, LLC | 65219-0650-50 | 500 | $39.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.078 | −$0.039 | 1 MG | Inj midazolam in 0.9% nacl | v1, posted September 17, 2026 |
| 3Q26 | $0.117 | −$0.042 | 1 MG | Inj midazolam in 0.9% nacl | v1, posted September 15, 2026 |
| 2Q26 | $0.159 | −$0.017 | 1 MG | Inj midazolam in 0.9% nacl | v1, posted September 15, 2026 |
| 1Q26 | $0.176 | −$0.028 | 1 MG | Inj midazolam in 0.9% nacl | v1, posted September 15, 2026 |
| 4Q25 | $0.204 | +$0.035 | 1 MG | Inj midazolam in 0.9% nacl | v1, posted September 8, 2026 |
| 3Q25 | $0.169 | −$0.001 | 1 MG | Inj midazolam in 0.9% nacl | v1, posted March 10, 2026 |
| 2Q25 | $0.17 | +$0.005 | 1 MG | Inj midazolam in 0.9% nacl | v1, posted March 10, 2026 |
| 1Q25 | $0.165 | −$0.012 | 1 MG | Inj midazolam in 0.9% nacl | v1, posted December 19, 2025 |
| 4Q24 | $0.177 | −$0.036 | 1 MG | Inj midazolam in 0.9% nacl | v1, posted June 11, 2025 |
| 3Q24 | $0.213 | −$0.047 | 1 MG | Inj midazolam (wg crit care) | v1, posted June 11, 2025 |
| 2Q24 | $0.26 | −$0.024 | 1 MG | Inj midazolam (wg crit care) | v1, posted March 11, 2025 |
| 1Q24 | $0.284 | −$0.008 | 1 MG | Inj midazolam (wg crit care) | v1, posted December 19, 2024 |
| 4Q23 | $0.292 | +$0.004 | 1 MG | Inj midazolam (wg crit care) | v1, posted October 10, 2024 |
| 3Q23 | $0.288 | −$0.019 | 1 MG | Inj midazolam (wg crit care) | v1, posted June 5, 2024 |
| 2Q23 | $0.307 | −$0.001 | 1 MG | Inj midazolam (wg crit care) | v1, posted February 23, 2024 |
| 1Q23 | $0.308 | – | 1 MG | Inj midazolam (wg crit care) | v1, posted December 6, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.